Supplier to Physiotherapists, General Public, the NHS & Armed Forces

IASLC Thoracic Oncology. Edition: 2

Not rated yet
0

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today's best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies.

141   – Reward points
Availability: IP - In print and in stock
    • 20% off
    £176.99, save £35.40
  • £141.59
Qty:  
In stock (14 items available)
  • Shipping info

    Our publishing partner, Elsevier, maintains a flat fee for shipping. Books are delivered in the UK via DHL and will require a signature upon delivery.

    The standard delivery time within the UK is 2 working days from the date of invoice.

    Manufactured on demand titles (Availability: MD) take an extra 3-5 working days.

    At this time we only ship Elsevier book orders to addresses within the UK.

    Brexit: We have been informed that some couriers are now charging additional fees for importing from the UK into the EU. The customer is responsible for the payment of any import duties that are in addition to the shipping costs already charged.

  • Payment methods

    logos-payments-tab_1.png

Section 1: Lung Cancer Control and Epidemiology

1. Classical Epidemiology

2. Tobacco Control and Primary Prevention

3. Tobacco Cessation

4. Non-Smoking Related Lung Cancer

5. Gender-Related Differences in Lung Cancer

6. Genetic Susceptibility to Lung Cancer

7. Early Detection and Radiologic Screening

8. Preclinical Biomarkers for The Early Detection of Lung Cancer

9. Chemoprevention of Lung Cancer: Present and Developing Technologies

Section 2: Lung Cancer Molecular Carcinogenesis

10. Copy Number Abnormalities and Gene Rearrangements in Lung Cancer: Present and Developing Technologies

11. Mutational Events in Lung Cancer: Present and Developing Technologies

12. Epigenetic Events, Alterations, and Remodeling in Lung Cancer: Present and Developing Technologies

13. Stem Cells and Lung Cancer: In Vitro and In Vivo Studies

14. Microenvironment and Lung Cancer

15. MicroRNAs as Biomarkers for Lung Cancer

Section 3: Immunology

16. Humoral and Cellular Immune Dysregulation and Lung Cancer

Section 4: Pathology

17. Classic Anatomic Pathology and Lung Cancer

18. Molecular Testing and Lung Cancer

19. Management of the Small Biopsy in the Molecular Er

Section 5: Clinical and Radiologic Presentation of Lung Cancer

20. Clinical Presentation

21. Conventional Imaging Lung Cancer

22. PET Imaging of Lung Cancer

Section 6: Diagnosis and Staging of Lung Cancer

23. Diagnostic Work-Up of Suspected Lung Cancer

24. Surgical Staging of the Mediastinum including Mediastinoscopy and Thoracoscopy, Preoperative and Intraoperative

25. The 8th Edition of the Tumor, Node and Metastasis Classification of Lung Cancer

Section 7: Surgical Management of Lung Cancer

26. Preoperative Functional Evaluation of the Surgical Candidate

27. Results of Video Assisted Techniques for Resection of Lung Cancer

28. Results of Robotic Techniques for Resection of Lung Cancer

29. Extent of Surgical Resection for Stage I and II Lung Cancer

30. Extended Resections for Lung Cancer: Chest Wall and Pancoast Tumors

31. Extended Resections for Lung Cancer: Broncho/Vascular Sleeve Resections

32. Multiple Nodules: Management of the Patient with Synchronous or Metachronous Lung Cancers

33. Surgical Management of the Marginally Resectable Patient

Section 8: Radiotherapeutic Management of Lung Cancer

34. Technical Requirements for Lung Cancer Radiotherapy

35. Radiobiology of Lung Cancer

36. Patient Selection for Radiotherapy

37. Stage I Non-Small Cell Lung Cancer and Oligometastatic Disease

38. Ablation Options for Localized Lung Cancer

39. Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer, including Combined Modality

40. Radiotherapy in the Management of Small Cell Lung Cancer: Thoracic Radiotherapy, Prophylactic Cranial Irradiation

41. Palliative Radiotherapy for Lung Cancer: Locoregional and Metastatic

42. Acute and Late Toxicities of Thoracic Radiotherapy: Pulmonary, Esophagus, Heart

43. Treatment-Related Neurotoxicity, Medical and Radiation Therapy

Section 9: Chemotherapy and Targeted Agents for Lung Cancer

44. Front-Line Systemic Options in Non-Small Cell Lung Cancer

45. Systemic Options in Second Line and Beyond

46. Maintenance Therapy in NSCLC

47. Pharmacogenomics and Lung Cancer

48. New Targetable Pathways in Lung Cancer

49. Management of Toxicities of Targeted Therapies

50. Immunotherapy and Lung Cancer

51. Systemic Therapy in Early-Stage NSCLC

52. Treatment of Small-Cell Lung Cancer

Section 10: Other Thoracic Malignancies

53. Malignant Mesothelioma

54. Mediastinal Tumors

55. Neuroendocrine Tumors of the Lung Other than SCLC

56. Thymic Cancer/Thymoma

Section 11: Symptom Management and Complications

57. Lung Cancer Emergencies

58. Role of Palliative Care in Lung Cancer

Section 12: Clinical Trials

59. Methodology of Clinical Trials in Lung Cancer

60. How to Promote and Organize Clinical Research in Lung Cancer

Section 13: Thoracic Oncology Advocacy

61. Role of Advocacy Groups in Lung Cancer

62. Health Services Research in Lung Cancer

Appendix

63. Appendix: Diagnostic Algorithms

    • SKU
      9780323523578
    • UPC/ISBN
      9780323523578
    • Stock Last Checked
      Mar 28, 2024
  • Manufacturer
    Elsevier
  • Publication Date
    Jun 23, 2017
Customer reviews
There are no comments yet. Be the first to leave a comment
Please sign in to add review

Your Elsevier book orders are actioned within 48hrs during the working week. If any one item in your purchase is delayed we will send you what is in stock and will send on the remainder as soon as it arrives. This is provided at no additional shipping cost to you. Stock availability levels are updated on a daily basis.  We ship directly from a UK warehouse.

Manufactured on demand titles (Availability: MD) take an extra 3-5 working days.

Shipping Costs

We currently maintain a flat fee structure for shipping book titles from Elsevier. Buy as many Elsevier titles as you like the we will still charge you the same single item shipping fee.

Overview Delivery Methods

Books are delivered in the UK via DHL and will require a signature upon delivery.

Deliveries within the UK

  • The standard delivery time within the UK is 2 working days from the date of invoice.
  • Print on demand titles take 3-5 working days.

Where is my order? Order Tracking

To find out more information about your order, select from the relevant options below:

Deliveries to the UK and UK shippers

Your order should be delivered to you/your shipper within 2-3 working days.

To track any deliveries using DPD, click here.

If your order is for a print on demand title, your delivery time will be longer, please allow an extra 3-5 working days.

We accept the following payment methods:

Elsevier maintains a standard returns policy